SLDB logo

Solid Biosciences (SLDB) Shareholders Equity

Annual Shareholders Equity

$137.25 M
+$10.77 M+8.51%

December 31, 2024


Summary


Performance

SLDB Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLDBbalance sheetmetrics:

Quarterly Shareholders Equity

$137.25 M
-$29.78 M-17.83%

December 31, 2024


Summary


Performance

SLDB Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLDBbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

SLDB Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.5%0.0%
3 y3 years-34.1%-16.2%
5 y5 years+71.5%-16.2%

SLDB Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-35.2%+8.5%-35.2%+8.5%
5 y5-year-35.2%+71.5%-45.8%+517.4%
alltimeall time-35.2%+262.7%-45.8%+262.7%

Solid Biosciences Shareholders Equity History

DateAnnualQuarterly
Dec 2024
$137.25 M(+8.5%)
$137.25 M(-17.8%)
Sep 2024
-
$167.02 M(-13.6%)
Jun 2024
-
$193.25 M(-8.3%)
Mar 2024
-
$210.72 M(+66.6%)
Dec 2023
$126.48 M(-40.2%)
$126.48 M(-12.4%)
Sep 2023
-
$144.36 M(-11.8%)
Jun 2023
-
$163.73 M(-10.9%)
Mar 2023
-
$183.79 M(-13.2%)
Dec 2022
$211.67 M(+1.7%)
$211.67 M(+47.7%)
Sep 2022
-
$143.28 M(-11.7%)
Jun 2022
-
$162.24 M(-12.5%)
Mar 2022
-
$185.51 M(-10.9%)
Dec 2021
$208.21 M(+57.6%)
$208.21 M(-6.8%)
Sep 2021
-
$223.36 M(-6.1%)
Jun 2021
-
$237.94 M(-6.0%)
Mar 2021
-
$253.00 M(+91.5%)
DateAnnualQuarterly
Dec 2020
$132.09 M(+65.0%)
$132.09 M(+494.2%)
Sep 2020
-
$22.23 M(-45.4%)
Jun 2020
-
$40.71 M(-27.9%)
Mar 2020
-
$56.46 M(-29.5%)
Dec 2019
$80.05 M(-36.1%)
$80.05 M(-26.2%)
Sep 2019
-
$108.53 M(+41.9%)
Jun 2019
-
$76.50 M(-22.8%)
Mar 2019
-
$99.11 M(-20.8%)
Dec 2018
$125.18 M(-311.3%)
$125.18 M(-13.7%)
Sep 2018
-
$145.07 M(-10.6%)
Jun 2018
-
$162.29 M(-9.3%)
Mar 2018
-
$178.95 M(-402.0%)
Dec 2017
-$59.26 M(-29.8%)
-$59.26 M(-351.2%)
Sep 2017
-
$23.59 M(-128.0%)
Dec 2016
-$84.36 M(+25.0%)
-$84.36 M
Dec 2015
-$67.51 M
-

FAQ

  • What is Solid Biosciences annual stockholders equity?
  • What is the all time high annual shareholders equity for Solid Biosciences?
  • What is Solid Biosciences annual shareholders equity year-on-year change?
  • What is Solid Biosciences quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Solid Biosciences?
  • What is Solid Biosciences quarterly shareholders equity year-on-year change?

What is Solid Biosciences annual stockholders equity?

The current annual shareholders equity of SLDB is $137.25 M

What is the all time high annual shareholders equity for Solid Biosciences?

Solid Biosciences all-time high annual stockholders equity is $211.67 M

What is Solid Biosciences annual shareholders equity year-on-year change?

Over the past year, SLDB annual stockholders equity has changed by +$10.77 M (+8.51%)

What is Solid Biosciences quarterly stockholders equity?

The current quarterly shareholders equity of SLDB is $137.25 M

What is the all time high quarterly shareholders equity for Solid Biosciences?

Solid Biosciences all-time high quarterly stockholders equity is $253.00 M

What is Solid Biosciences quarterly shareholders equity year-on-year change?

Over the past year, SLDB quarterly stockholders equity has changed by $0.00 (0.00%)